PATTERSON LEONE D
Insider CIK 1233539 · DDXS Chief Financial Officer · TSPT Vice President, CFO · ADVM SVP, CFO, Interim Pres and CEO, Director · KLRS Director · ELYM Director · NKTX Director · TNYA Chief Fin. and Bus. Officer · ZYME EVP, Chief Bus & Fin Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NKTX Nkarta, Inc. | A Award deriv | 2026-06-10 | 2026-06-11 | 37,000 | — | $0 | 37,000 | SEC↗ |
| KLRS Kalaris Therapeutics, Inc. | A Award deriv | 2026-06-03 | 2026-06-04 | 9,000 | — | $0 | 9,000 | SEC↗ |
| ZYME Zymeworks Inc. | A Award | 2026-01-06 | 2026-01-07 | 459 | $10.55 | $4.8K | 459 | SEC↗ |
| NKTX Nkarta, Inc. | A Award deriv | 2025-06-05 | 2025-06-09 | 46,000 | — | $0 | 46,000 | SEC↗ |
| KLRS Kalaris Therapeutics, Inc. | A Award deriv | 2025-04-10 | 2025-04-11 | 18,000 | — | $0 | 18,000 | SEC↗ |
| ZYME Zymeworks Inc. | A Award deriv | 2025-01-10 | 2025-01-10 | 79,000 | — | $0 | 79,000 | SEC↗ |
| ZYME Zymeworks Inc. | A Award deriv | 2025-01-10 | 2025-01-10 | 53,000 | — | $0 | 53,000 | SEC↗ |
| ZYME Zymeworks Inc. | A Award deriv | 2024-09-01 | 2024-09-03 | 360,000 | — | $0 | 360,000 | SEC↗ |
| NKTX Nkarta, Inc. | A Award deriv | 2024-06-13 | 2024-06-14 | 22,500 | — | $0 | 22,500 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | A Award deriv | 2024-02-23 | 2024-02-27 | 205,000 | — | $0 | 205,000 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | A Award | 2024-02-23 | 2024-02-27 | 35,000 | — | $0 | 95,755 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | S Sale | 2024-02-16 | 2024-02-16 | 5,201 | $5.86 | $30.5K | 60,755 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | S Sale | 2023-08-16 | 2023-08-18 | 4,452 | $3.81 | $17.0K | 64,542 | SEC↗ |
| NKTX Nkarta, Inc. | A Award deriv | 2023-06-07 | 2023-06-09 | 22,500 | — | $0 | 22,500 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | A Award deriv | 2023-02-15 | 2023-02-17 | 190,000 | — | $0 | 190,000 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | A Award | 2023-02-15 | 2023-02-17 | 35,000 | — | $0 | 67,000 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | A Award | 2023-02-15 | 2023-02-17 | 30,000 | — | $0 | 32,000 | SEC↗ |
| NKTX Nkarta, Inc. | A Award deriv | 2022-06-08 | 2022-06-10 | 16,000 | — | $0 | 16,000 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | A Award deriv | 2022-05-19 | 2022-06-01 | 10,000 | — | $0 | 10,000 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | A Award deriv | 2022-02-15 | 2022-02-17 | 66,000 | — | $0 | 66,000 | SEC↗ |
| NKTX Nkarta, Inc. | A Award deriv | 2021-06-13 | 2021-06-15 | 16,511 | — | $0 | 16,511 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2021-02-16 | 2021-02-18 | 240,000 | — | $0 | 240,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | S Sale | 2021-02-09 | 2021-02-11 | 62 | $14.14 | $877 | 97,955 | SEC↗ |
| ADVM Adverum Biotechnologies, I | S Sale | 2021-02-09 | 2021-02-11 | 12,471 | $14.10 | $175.8K | 98,017 | SEC↗ |
| NKTX Nkarta, Inc. | A Award deriv | 2020-07-09 | 2020-07-13 | 18,300 | — | $0 | 18,300 | SEC↗ |
| NKTX Nkarta, Inc. | A Award deriv | 2020-07-09 | 2020-07-13 | 10,700 | — | $0 | 10,700 | SEC↗ |
| ADVM Adverum Biotechnologies, I | S Sale | 2020-06-16 | 2020-06-17 | 13,171 | $24.68 | $325.1K | 110,488 | SEC↗ |
| ADVM Adverum Biotechnologies, I | M Exercise deriv | 2020-05-06 | 2020-05-08 | 20,000 | — | $0 | 155,576 | SEC↗ |
| ADVM Adverum Biotechnologies, I | M Exercise | 2020-05-06 | 2020-05-08 | 20,000 | $3.44 | $68.8K | 143,659 | SEC↗ |
| ADVM Adverum Biotechnologies, I | S Sale | 2020-05-06 | 2020-05-08 | 20,000 | $20.02 | $400.4K | 123,659 | SEC↗ |
| ADVM Adverum Biotechnologies, I | M Exercise deriv | 2020-03-20 | 2020-03-25 | 24,424 | — | $0 | 175,576 | SEC↗ |
| ADVM Adverum Biotechnologies, I | S Sale | 2020-03-20 | 2020-03-25 | 39,526 | $10.17 | $402.0K | 123,429 | SEC↗ |
| ADVM Adverum Biotechnologies, I | M Exercise | 2020-03-20 | 2020-03-25 | 24,424 | $3.44 | $84.0K | 162,955 | SEC↗ |
| ADVM Adverum Biotechnologies, I | S Sale | 2020-03-17 | 2020-03-18 | 474 | $10.02 | $4.7K | 138,531 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2020-02-20 | 2020-02-21 | 300,000 | — | $0 | 300,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | F Tax w/h | 2020-02-09 | 2020-05-08 | 10,985 | $10.24 | $112.5K | 139,235 | SEC↗ |
| ADVM Adverum Biotechnologies, I | F Tax w/h | 2020-02-09 | 2020-02-10 | 11,215 | $10.24 | $114.8K | 139,005 | SEC↗ |
| ADVM Adverum Biotechnologies, I | S Sale | 2019-12-23 | 2020-02-10 | 40,000 | $10.72 | $428.8K | 150,220 | SEC↗ |
| ADVM Adverum Biotechnologies, I | S Sale | 2019-12-23 | 2019-12-26 | 40,000 | $10.72 | $428.8K | 228,496 | SEC↗ |
| ADVM Adverum Biotechnologies, I | F Tax w/h | 2019-06-15 | 2020-02-10 | 8,570 | $10.82 | $92.7K | 225,502 | SEC↗ |
| ADVM Adverum Biotechnologies, I | F Tax w/h | 2019-06-15 | 2020-02-10 | 35,282 | $10.82 | $381.8K | 190,220 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2019-02-14 | 2019-02-19 | 800,000 | — | $0 | 800,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | F Tax w/h | 2019-02-09 | 2020-02-10 | 8,176 | $3.33 | $27.2K | 234,072 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2018-10-18 | 2018-10-22 | 150,000 | — | $0 | 150,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | F Tax w/h | 2018-06-15 | 2020-02-10 | 8,645 | $5.55 | $48.0K | 242,248 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award | 2018-06-15 | 2018-06-18 | 88,496 | — | $0 | 268,496 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2018-02-15 | 2018-02-20 | 160,000 | — | $0 | 160,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | F Tax w/h | 2018-02-09 | 2020-02-10 | 8,208 | $7.05 | $57.9K | 162,397 | SEC↗ |
| ADVM Adverum Biotechnologies, I | F Tax w/h | 2017-06-15 | 2020-02-10 | 9,395 | $2.70 | $25.4K | 170,605 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2017-02-09 | 2017-02-13 | 116,000 | — | $0 | 116,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award | 2017-02-09 | 2017-02-13 | 80,000 | — | $0 | 180,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2016-06-15 | 2016-06-16 | 200,000 | — | $0 | 200,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award | 2016-06-15 | 2016-06-16 | 100,000 | — | $0 | 100,000 | SEC↗ |
| DDXS diaDexus, Inc. | A Award deriv | 2015-03-20 | 2015-03-24 | 700,000 | — | $0 | 700,000 | SEC↗ |
| TSPT Transcept Pharmaceuticals | D To issuer deriv | 2014-10-30 | 2014-10-30 | 9,583 | — | $0 | 0 | SEC↗ |
| TSPT Transcept Pharmaceuticals | D To issuer deriv | 2014-10-30 | 2014-10-30 | 7,500 | — | $0 | 0 | SEC↗ |
| TSPT Transcept Pharmaceuticals | D To issuer deriv | 2014-10-30 | 2014-10-30 | 6,666 | — | $0 | 0 | SEC↗ |
| TSPT Transcept Pharmaceuticals | A Award | 2014-10-30 | 2014-10-30 | 4,161 | $21.59 | $89.8K | 4,161 | SEC↗ |
| TSPT Transcept Pharmaceuticals | A Award deriv | 2013-07-15 | 2013-07-18 | 115,000 | — | $0 | 115,000 | SEC↗ |
| TSPT Transcept Pharmaceuticals | A Award deriv | 2013-01-07 | 2013-01-08 | 80,000 | — | $0 | 80,000 | SEC↗ |
| TSPT Transcept Pharmaceuticals | A Award deriv | 2012-06-25 | 2012-06-26 | 90,000 | — | $0 | 90,000 | SEC↗ |